Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-κB activation and expression

Cell Stress and Chaperones

Volumn 13, Issue 3, 2008, Pages 287-296

  Frier, Bruce C ^a   Noble, Earl G ^a   Locke, Marius ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes mellitus; Diabetes induced atrophy; Gastrocnemius; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 3; PROTEIN P50; PROTEIN P52; STREPTOZOCIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELB; PROTEIN SUBUNIT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; GASTROCNEMIUS MUSCLE; GEL MOBILITY SHIFT ASSAY; MALE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SOLEUS MUSCLE; SPRAGUE DAWLEY RAT; TISSUE SPECIFICITY; WESTERN BLOTTING; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; TRANSACTIVATION;

ANIMALIA; RATTUS;

ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NF-KAPPA B; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; TRANS-ACTIVATION (GENETICS);

EID: 53149137109     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-008-0062-0     Document Type: Article

References (40)

1. Armstrong RB, Laughlin MH (1985) Metabolic indicators of fibre recruitment in mammalian muscles during locomotion. J Exp Biol 115:201-213 (Pubitemid 15068826)
2. Armstrong RB, Gollnick PD, Ianuzzo CD (1975) Histochemical properties of skeletal muscle fibers in streptozotocin-diabetic rats. Cell Tissue Res 162:387-394
3. Bosisio D, Marazzi I, Agresti A, Shimizu N, Bianchi ME, Natoli G (2006) A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J 25:798-810 (Pubitemid 43292441)
4. Cai D, Frantz JD, Tawa NE Jr, Melendez PA et al (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285-298 (Pubitemid 39360909)
5. Chaudhury SK, Mandal MB, Deshpande SB, Saxena ID (1994) Effect of streptozotocin-induced diabetes on growth and proteolytic activity of different muscles in rats. Indian J Exp Biol 32:877-880 (Pubitemid 24364517)
6. Chen V, Ianuzzo CD (1982) Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60:1251-1256 (Pubitemid 13218548)
7. Cogswell PC, Scheinman RI, Baldwin AS Jr (1993) Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J Immunol 150:2794-2804
8. Derudder E, Laferte A, Ferreira V, Mishal Z, Baud V, Tarantino N, Korner M (2003) Identification and characterization of p100HB, a new mutant form of p100/NF-kappa B2. Biochem Biophys Res Commun 308:744-749 (Pubitemid 36976525)
9. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52:442-447 (Pubitemid 36173201)
10. Fan C, Yang J, Engelhardt JF (2002) Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. J Cell Sci 115:4843-4853 (Pubitemid 36054637)
11. Gilmore TD (2006) Introduction to NF-kB: players, pathways, perspectives. Oncogene 25:6680-6684 (Pubitemid 44657845)
12. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr (2000) NF-kB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363-2366
13. Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25:6706-6716 (Pubitemid 44657847)
14. Hunter RB, Kandarian SC (2004) Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114:1504-1511 (Pubitemid 40385580)
15. Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC (2002) Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 16:529-538 (Pubitemid 34273236)
16. Kaliman P, Canicio J, Testar X, Palacin M, Zorzano A (1999) Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J Biol Chem 274:17437-17444 (Pubitemid 129519087)
17. Kashatus D, Cogswell P, Baldwin AS (2006) Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev 20:225-235 (Pubitemid 43112940)
18. Kefaloyianni E, Gaitanaki C, Beis I (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18:2238-2251
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. Lecker SH, Jagoe RT, Gilbert A et al (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18:39-51 (Pubitemid 38076464)
21. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE (2004) Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15:1537-1545 (Pubitemid 38679678)
22. Liptay S, Schmid RM, Nabel EG, Nabel GJ (1994) Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation. Mol Cell Biol 14:7695-7703 (Pubitemid 24373521)
23. Locke M, Tanguay RM (1996) Increased HSF activation in muscles with a high constitutive Hsp70 expression. Cell Stress Chaperones 1:189-196 (Pubitemid 126672402)
24. Locke M, Tanguay RM, Klabunde RE, Ianuzzo CD (1995) Enhanced postischemic myocardial recovery following exercise induction of HSP 72. Am J Physiol 269:320-325
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
26. McFarlane C, Plummer E, Thomas M et al (2006) Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 209:501-514
27. Mourkioti F, Kratsios P, Luedde T et al (2006) Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 116:2945-2954 (Pubitemid 44684479)
28. Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790 (Pubitemid 30212409)
29. Phillips T, Leeuwenburgh C (2005) Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J 19:668-670 (Pubitemid 40471280)
30. Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, Mitch WE (1996) Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98:1703-1708 (Pubitemid 26359185)
31. Rebollo A, Dumoutier L, Renauld JC, Zaballos A, Ayllon V, Martinez-A C (2000) Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol Cell Biol 20:3407-3416 (Pubitemid 30243886)
32. Schwarz EM, Krimpenfort P, Berns A, Verma IM (1997) Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev 11:187-197 (Pubitemid 27082323)
33. Shiio Y, Sawada J, Handa H, Yamamoto T, Inoue J (1996) Activation of the retinoblastoma gene expression by Bcl-3: implication for muscle cell differentiation. Oncogene 12:1837-1845 (Pubitemid 26154655)
34. Smahi A, Courtois G, Vabres P et al (2000) Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405:466-472
35. Tong X, Yin L, Washington R, Rosenberg DW, Giardina C (2004) The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265:171-183 (Pubitemid 41461877)
36. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24:145-149 (Pubitemid 9256559)
37. Wyke SM, Tisdale MJ (2005) NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 92:711-721 (Pubitemid 40460608)
38. Xiao G, Harhaj EW, Sun SC (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7:401-409 (Pubitemid 32206507)
39. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R (1999) Hyperglycemia induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48:855-864 (Pubitemid 29153087)
40. Yui MA, Rothenberg EV (2004) Deranged early T cell development in immunodeficient strains of nonobese diabetic mice. J Immunol 173:5381-5391 (Pubitemid 39392121)